Dipexium Pharmaceuticals' Merger

Dipexium Pharmaceuticals raised a round of funding on April 19, 2017. Investors include PLx Pharma.

Dipexium Pharmaceuticals (NASDAQ: DPRX) is a late-stage pharmaceutical company focused on the development and commercialization of Locilex (pexiganan cream 1%), a broad-spectrum, topical antibiotic pe…

Articles about Dipexium Pharmaceuticals' Merger: